Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Mycobacterial biomaterials and resources for researchers.

Hazbón MH, Rigouts L, Schito M, Ezewudo M, Kudo T, Itoh T, Ohkuma M, Kiss K, Wu L, Ma J, Hamada M, Strong M, Salfinger M, Daley CL, Nick JA, Lee JS, Rastogi N, Couvin D, Hurtado-Ortiz R, Bizet C, Suresh A, Rodwell T, Albertini A, Lacourciere KA, Deheer-Graham A, Alexander S, Russell JE, Bradford R, Riojas MA.

Pathog Dis. 2018 Jun 1;76(4). doi: 10.1093/femspd/fty042. Review.

2.

The global catalogue of microorganisms 10K type strain sequencing project: closing the genomic gaps for the validly published prokaryotic and fungi species.

Wu L, McCluskey K, Desmeth P, Liu S, Hideaki S, Yin Y, Moriya O, Itoh T, Kim CY, Lee JS, Zhou Y, Kawasaki H, Hazbón MH, Robert V, Boekhout T, Lima N, Evtushenko L, Boundy-Mills K, Bunk B, Moore ERB, Eurwilaichitr L, Ingsriswang S, Shah H, Yao S, Jin T, Huang J, Shi W, Sun Q, Fan G, Li W, Li X, Kurtböke I, Ma J.

Gigascience. 2018 May 1;7(5). doi: 10.1093/gigascience/giy026.

3.
4.

Multiplex PCR for species-level identification of Bacillus anthracis and detection of pXO1, pXO2, and related plasmids.

Riojas MA, Kiss K, McKee ML, Hazbón MH.

Health Secur. 2015 Mar-Apr;13(2):122-9. Epub 2015 Mar 20.

5.

Multiplexed Luminex xMAP assay for detection and identification of five adenovirus serotypes associated with epidemics of respiratory disease in adults.

Washington C, Metzgar D, Hazbón MH, Binn L, Lyons A, Coward C, Kuschner R.

J Clin Microbiol. 2010 Jun;48(6):2217-22. doi: 10.1128/JCM.00029-10. Epub 2010 Apr 21.

6.

Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis.

Vilchèze C, Av-Gay Y, Attarian R, Liu Z, Hazbón MH, Colangeli R, Chen B, Liu W, Alland D, Sacchettini JC, Jacobs WR Jr.

Mol Microbiol. 2008 Sep;69(5):1316-29. doi: 10.1111/j.1365-2958.2008.06365.x. Epub 2008 Jul 21.

7.

Convergent evolutionary analysis identifies significant mutations in drug resistance targets of Mycobacterium tuberculosis.

Hazbón MH, Motiwala AS, Cavatore M, Brimacombe M, Whittam TS, Alland D.

Antimicrob Agents Chemother. 2008 Sep;52(9):3369-76. doi: 10.1128/AAC.00309-08. Epub 2008 Jun 30.

8.

Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin.

Safi H, Sayers B, Hazbón MH, Alland D.

Antimicrob Agents Chemother. 2008 Jun;52(6):2027-34. doi: 10.1128/AAC.01486-07. Epub 2008 Mar 31.

9.

Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M. tuberculosis.

Colangeli R, Helb D, Vilchèze C, Hazbón MH, Lee CG, Safi H, Sayers B, Sardone I, Jones MB, Fleischmann RD, Peterson SN, Jacobs WR Jr, Alland D.

PLoS Pathog. 2007 Jun;3(6):e87.

10.

Role of large sequence polymorphisms (LSPs) in generating genomic diversity among clinical isolates of Mycobacterium tuberculosis and the utility of LSPs in phylogenetic analysis.

Alland D, Lacher DW, Hazbón MH, Motiwala AS, Qi W, Fleischmann RD, Whittam TS.

J Clin Microbiol. 2007 Jan;45(1):39-46. Epub 2006 Nov 1.

11.

Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.

Vilchèze C, Wang F, Arai M, Hazbón MH, Colangeli R, Kremer L, Weisbrod TR, Alland D, Sacchettini JC, Jacobs WR Jr.

Nat Med. 2006 Sep;12(9):1027-9. Epub 2006 Aug 13.

PMID:
16906155
12.

Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.

Hazbón MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, García-García L, León CI, Bose M, Chaves F, Murray M, Eisenach KD, Sifuentes-Osornio J, Cave MD, Ponce de León A, Alland D.

Antimicrob Agents Chemother. 2006 Aug;50(8):2640-9.

13.

Arginine homeostasis in J774.1 macrophages in the context of Mycobacterium bovis BCG infection.

Talaue MT, Venketaraman V, Hazbón MH, Peteroy-Kelly M, Seth A, Colangeli R, Alland D, Connell ND.

J Bacteriol. 2006 Jul;188(13):4830-40.

14.

Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set.

Filliol I, Motiwala AS, Cavatore M, Qi W, Hazbón MH, Bobadilla del Valle M, Fyfe J, García-García L, Rastogi N, Sola C, Zozio T, Guerrero MI, León CI, Crabtree J, Angiuoli S, Eisenach KD, Durmaz R, Joloba ML, Rendón A, Sifuentes-Osornio J, Ponce de León A, Cave MD, Fleischmann R, Whittam TS, Alland D.

J Bacteriol. 2006 Jan;188(2):759-72. Erratum in: J Bacteriol. 2006 Apr;188(8):3162-3.

15.

Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance.

Hazbón MH, Bobadilla del Valle M, Guerrero MI, Varma-Basil M, Filliol I, Cavatore M, Colangeli R, Safi H, Billman-Jacobe H, Lavender C, Fyfe J, García-García L, Davidow A, Brimacombe M, León CI, Porras T, Bose M, Chaves F, Eisenach KD, Sifuentes-Osornio J, Ponce de León A, Cave MD, Alland D.

Antimicrob Agents Chemother. 2005 Sep;49(9):3794-802. Erratum in: Antimicrob Agents Chemother. 2005 Nov;49(11):4818.

16.

The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.

Colangeli R, Helb D, Sridharan S, Sun J, Varma-Basil M, Hazbón MH, Harbacheuski R, Megjugorac NJ, Jacobs WR Jr, Holzenburg A, Sacchettini JC, Alland D.

Mol Microbiol. 2005 Mar;55(6):1829-40.

17.

Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria.

Vilchèze C, Weisbrod TR, Chen B, Kremer L, Hazbón MH, Wang F, Alland D, Sacchettini JC, Jacobs WR Jr.

Antimicrob Agents Chemother. 2005 Feb;49(2):708-20.

18.

Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana.

Saravia NG, Hazbón MH, Osorio Y, Valderrama L, Walker J, Santrich C, Cortázar T, Lebowitz JH, Travi BL.

Vaccine. 2005 Jan 11;23(8):984-95.

PMID:
15620471
19.

Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay.

Varma-Basil M, El-Hajj H, Colangeli R, Hazbón MH, Kumar S, Bose M, Bobadilla-del-Valle M, García LG, Hernández A, Kramer FR, Osornio JS, Ponce-de-León A, Alland D.

J Clin Microbiol. 2004 Dec;42(12):5512-6.

20.
21.

Novel hairpin-shaped primer assay to study the association of the -44 single-nucleotide polymorphism of the DEFB1 gene with early-onset periodontal disease.

Boniotto M, Hazbón MH, Jordan WJ, Lennon GP, Eskdale J, Alland D, Gallagher G.

Clin Diagn Lab Immunol. 2004 Jul;11(4):766-9.

22.

Molecular beacons for multiplex detection of four bacterial bioterrorism agents.

Varma-Basil M, El-Hajj H, Marras SA, Hazbón MH, Mann JM, Connell ND, Kramer FR, Alland D.

Clin Chem. 2004 Jun;50(6):1060-2. No abstract available.

24.

Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates.

Hazbón MH, Guarín N, Ferro BE, Rodríguez AL, Labrada LA, Tovar R, Riska PF, Jacobs WR Jr.

J Clin Microbiol. 2003 Oct;41(10):4865-9.

25.

Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesis.

Alland D, Whittam TS, Murray MB, Cave MD, Hazbon MH, Dix K, Kokoris M, Duesterhoeft A, Eisen JA, Fraser CM, Fleischmann RD.

J Bacteriol. 2003 Jun;185(11):3392-9.

26.

Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.

Larsen MH, Vilchèze C, Kremer L, Besra GS, Parsons L, Salfinger M, Heifets L, Hazbon MH, Alland D, Sacchettini JC, Jacobs WR Jr.

Mol Microbiol. 2002 Oct;46(2):453-66.

27.

Evaluation of Etest for susceptibility testing of multidrug-resistant isolates of Mycobacterium tuberculosis.

Hazbón MH, del Socorro Orozco M, Labrada LA, Tovar R, Weigle KA, Wanger A.

J Clin Microbiol. 2000 Dec;38(12):4599-603.

28.

Clinical and programmatic mismanagement rather than community outbreak as the cause of chronic, drug-resistant tuberculosis in Buenaventura, Colombia, 1998.

Laserson KF, Osorio L, Sheppard JD, Hernández H, Benitez AM, Brim S, Woodley CL, Hazbón MH, Villegas MV, Castaño MC, Henriquez N, Rodriguez E, Metchock B, Binkin NJ.

Int J Tuberc Lung Dis. 2000 Jul;4(7):673-83.

PMID:
10907771

Supplemental Content

Loading ...
Support Center